| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ... The lancet Infectious diseases 18 (4), 391-400, 2018 | 584 | 2018 |
| Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A … E Durante-Mangoni, G Signoriello, R Andini, A Mattei, M De Cristoforo, ... Clinical infectious diseases 57 (3), 349-358, 2013 | 468 | 2013 |
| Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ... European journal of clinical pharmacology 67, 507-519, 2011 | 411 | 2011 |
| European heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by … C Blomström-Lundqvist, V Traykov, PA Erba, H Burri, JC Nielsen, ... European Journal of Cardio-Thoracic Surgery 57 (1), e1-e31, 2020 | 409 | 2020 |
| Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study E Durante-Mangoni, S Bradley, C Selton-Suty, MF Tripodi, B Barsic, ... Archives of internal medicine 168 (19), 2095-2103, 2008 | 355 | 2008 |
| Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices E Athan, VH Chu, P Tattevin, C Selton-Suty, P Jones, C Naber, JM Miró, ... Jama 307 (16), 1727-1735, 2012 | 346 | 2012 |
| Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis LE Adinolfi, MG Giordano, A Andreana, MF Tripodi, R Utili, G Cesaro, ... British journal of haematology 113 (3), 590-595, 2001 | 319 | 2001 |
| The 2023 Duke-International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria VG Fowler Jr, DT Durack, C Selton-Suty, E Athan, AS Bayer, AL Chamis, ... Clinical Infectious Diseases 77 (4), 518-526, 2023 | 297 | 2023 |
| In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis T Lalani, VH Chu, LP Park, E Cecchi, GR Corey, E Durante-Mangoni, ... JAMA internal medicine 173 (16), 1495-1504, 2013 | 294 | 2013 |
| Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis VH Chu, LP Park, E Athan, F Delahaye, T Freiberger, C Lamas, JM Miro, ... Circulation 131 (2), 131-140, 2015 | 290 | 2015 |
| Do we still need the aminoglycosides? E Durante-Mangoni, A Grammatikos, R Utili, ME Falagas International journal of antimicrobial agents 33 (3), 201-205, 2009 | 290 | 2009 |
| Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure T Kiefer, L Park, C Tribouilloy, C Cortes, R Casillo, V Chu, F Delahaye, ... Jama 306 (20), 2239-2247, 2011 | 289 | 2011 |
| Combination therapy for carbapenem-resistant Gram-negative bacteria M Paul, Y Carmeli, E Durante-Mangoni, JW Mouton, E Tacconelli, ... Journal of Antimicrobial Chemotherapy 69 (9), 2305-2309, 2014 | 266 | 2014 |
| Management of carbapenem-resistant Enterobacteriaceae infections E Durante-Mangoni, R Andini, R Zampino Clinical Microbiology and Infection 25 (8), 943-950, 2019 | 263 | 2019 |
| Global Spread of Drug-Resistant Acinetobacter Baumannii: Molecular Epidemiology And Management Of Antimicrobial Resistance E Durante-Mangoni, R Zarrilli Future microbiology 6 (4), 407-422, 2011 | 254 | 2011 |
| HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort ST Chambers, D Murdoch, A Morris, D Holland, P Pappas, M Almela, ... PloS one 8 (5), e63181, 2013 | 229 | 2013 |
| Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis S Leone, V Ravasio, E Durante-Mangoni, M Crapis, G Carosi, PG Scotton, ... Infection 40, 527-535, 2012 | 205 | 2012 |
| Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells E Durante-Mangoni, RJ Wang, A Shaulov, Q He, I Nasser, N Afdhal, ... The Journal of Immunology 173 (3), 2159-2166, 2004 | 165 | 2004 |
| Risk factors for “major” embolic events in hospitalized patients with infective endocarditis ED Mangoni, LE Adinolfi, MF Tripodi, A Andreana, M Gambardella, ... American heart journal 146 (2), 311-316, 2003 | 160 | 2003 |
| Validated risk score for predicting 6‐month mortality in infective endocarditis LP Park, VH Chu, G Peterson, A Skoutelis, T Lejko‐Zupa, E Bouza, ... Journal of the American Heart Association 5 (4), e003016, 2016 | 158 | 2016 |